TABLE OF CONTENTS
1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 OVERVIEW OF GLOBAL ENTERAL FEEDING FORMULA MARKET 28
1.4 CURRENCY AND PRICING 29
1.5 LIMITATION 29
1.6 MARKETS COVERED 30
2 MARKET SEGMENTATION 33
2.1 MARKETS COVERED 33
2.2 GEOGRAPHIC SCOPE 34
2.3 YEARS CONSIDERED FOR THE STUDY 35
2.4 CURRENCY AND PRICING 35
2.5 RESEARCH METHODOLOGY 36
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.7 DBMR MARKET CHALLENGE MATRIX 40
2.8 SECONDARY SOURCES 41
2.9 ASSUMPTIONS 41
3 MARKET OVERVIEW 42
3.1 DRIVERS 44
3.1.1 RISING NUMBER OF PRETERM BIRTH 44
3.1.2 GROWING NUMBER OF CHRONIC DISEASES 45
3.1.3 GROWING BUSINESS EXPANSION FOR NUTRITIONAL SUPPLY 46
3.1.4 GROWING NEED OF NUTRITIONAL CARE FOR GERIATRIC POPULATION 46
3.2 RESTRAINTS 48
3.2.1 RISK ASSOCIATED WITH THE ENTERAL TUBE FEEDING 48
3.2.2 STRICT REGULATION OF USAGE FOR PATIENTS SAFETY 48
3.3 OPPORTUNITIES 49
3.3.1 GROWTH IN HEALTHCARE EXPENDITURE OF DEVELOPING ECONOMIES 49
3.4 CHALLENGES 50
3.4.1 INSUFFICIENT REIMBURSEMENTS POLICIES 50
3.4.2 LACK OF TRAINED STAFF 50
4 EXECUTIVE SUMMARY 51
5 PREMIUM INSIGHTS 55
6 GLOBAL ENTERAL FEEDING FORMULA MARKET, BY PRODUCT 58
6.1 OVERVIEW 59
6.2 STANDARD FORMULAS 61
6.2.1 MONOMERIC 61
6.2.2 POLYMERIC 61
6.3 DISEASE SPECIFIC 62
6.3.1 DIABETIC FORMULAS 62
6.3.2 RENAL FORMULAS 62
6.3.3 HEPATIC FORMULAS 63
6.3.4 PULMONARY FORMULAS 63
6.3.5 OTHERS 63
7 GLOBAL ENTERAL FEEDING FORMULA MARKET, BY APPLICATION 64
7.1 OVERVIEW 65
7.2 CRITICAL CARE 66
7.3 GASTROENTEROLOGY 67
7.4 ONCOLOGY 67
7.5 NEUROLOGY 68
7.6 DIABETES 69
7.7 OTHERS 69
8 GLOBAL ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING 70
8.1 OVERVIEW 71
8.2 GASTRIC TUBE FEEDING 73
8.3 NASOGASTRIC TUBE FEEDING 73
8.4 GASTROTOMY TUBE FEEDING 74
8.5 DUODENAL OR JEJUNAL TUBE FEEDING 75
9 GLOBAL ENTERAL FEEDING FORMULA MARKET, BY STAGE 76
9.1 OVERVIEW 77
9.2 ADULT 79
9.3 PEDIATRIC 79
10 GLOBAL ENTERAL FEEDING FORMULA MARKET, BY END USER 80
10.1 OVERVIEW 81
10.2 HOSPITALS 82
10.3 LONG TERM CARE FACILITIES 83
10.3.1 HOME CARE AGENCIES AND HOSPICES 84
10.3.2 NURSING HOMES 84
10.3.3 ASSISTED LIVING FACILITIES 84
11 GLOBAL ENTERAL FEEDING FORMULA MARKET, BY GEOGRAPHY 85
11.1 OVERVIEW 86
11.2 NORTH AMERICA 91
11.2.1 U.S. 98
11.2.2 CANADA 101
11.2.3 MEXICO 104
11.3 EUROPE 107
11.3.1 GERMANY 114
11.3.2 U.K. 117
11.3.3 FRANCE 120
11.3.4 SPAIN 123
11.3.5 ITALY 126
11.3.6 SWITZERLAND 129
11.3.7 NETHERLAND 132
11.3.8 NORWAY 135
11.3.9 BELGIUM 138
11.3.10 RUSSIA 141
11.3.11 POLAND 144
11.3.12 TURKEY 147
11.3.13 REST OF EUROPE 150
11.4 ASIA PACIFIC 151
11.4.1 CHINA 158
11.4.2 INDIA 161
11.4.3 JAPAN 164
11.4.4 SOUTH KOREA 167
11.4.5 AUSTRALIA 170
11.4.6 SINGAPORE 173
11.4.7 THAILAND 176
11.4.8 MALAYSIA 179
11.4.9 INDONESIA 182
11.4.10 PHILIPPINES 185
11.4.11 REST OF ASIA-PACIFIC 188
11.5 SOUTH AMERICA 189
11.5.1 BRAZIL 196
11.5.2 ARGENTINA 199
11.5.3 COLOMBIA 202
11.5.4 CHILE 205
11.5.5 REST OF SOUTH AMERICA 208
?
11.6 MIDDLE EAST & AFRICA 209
11.6.1 SOUTH AFRICA 216
11.6.2 REST OF MIDDLE EAST & AFRICA 219
12 GLOBAL ENTERAL FEEDING FORMULA MARKET, COMPANY LANDSCAPE 220
12.1 COMPANY SHARE ANALYSIS; GLOBAL 220
12.2 COMPANY SHARE ANALYSIS; NORTH AMERICA 221
12.3 COMPANY SHARE ANALYSIS; EUROPE 222
12.4 COMPANY SHARE ANALYSIS; ASIA-PACIFIC 223
13 COMPANY PROFILE 224
13.1 ABBOTT 224
13.1.1 COMPANY SNAPSHOT 224
13.1.2 REVENUE ANALYSIS 224
13.1.3 COMPANY SHARE ANALYSIS 225
13.1.4 PRODUCT PORTFOLIO 225
13.1.5 RECENT DEVELOPMENTS 228
13.2 NESTL? 229
13.2.1 COMPANY OVERVIEW 229
13.2.2 REVENUE ANALYSIS 229
13.2.3 COMPANY SHARE ANALYSIS 230
13.2.4 PRODUCT PORTFOLIO 230
13.2.5 RECENT DEVELOPMENTS 231
13.3 MEIJI HOLDINGS CO., LTD. 232
13.3.1 COMPANY OVERVIEW 232
13.3.2 REVENUE ANALYSIS 232
13.3.3 COMPANY SHARE ANALYSIS 233
13.3.4 PRODUCT PORTFOLIO 233
13.3.5 RECENT DEVELOPMENTS 234
13.4 B. BRAUN MELSUNGEN AG 235
13.4.1 COMPANY SNAPSHOT 235
13.4.2 REVENUE ANALYSIS 235
13.4.3 COMPANY SHARE ANALYSIS 236
13.4.4 PRODUCT PORTFOLIO 236
13.4.5 RECENT DEVELOPMENTS 237
13.5 DANONE NUTRICIA 238
13.5.1 COMPANY SNAPSHOT 238
13.5.2 GEOGRAPHICAL PRESENCE 238
13.5.3 PRODUCT PORTFOLIO 239
13.5.4 RECENT DEVELOPMENTS 241
13.6 FRESENIUS SE & CO. KGAA 242
13.6.1 COMPANY SNAPSHOT 242
13.6.2 REVENUE ANALYSIS 242
13.6.3 PRODUCT PORTFOLIO 243
13.6.4 RECENT DEVELOPMENTS 243
13.7 GLOBAL HEALTH PRODUCTS, INC. 244
13.7.1 COMPANY SNAPSHOT 244
13.7.2 PRODUCT PORTFOLIO 244
13.7.3 RECENT DEVELOPMENT 245
13.8 HORMEL FOODS, LLC 246
13.8.1 COMPANY SNAPSHOT 246
13.8.2 GEOGRAPHICAL PRESENCE 246
13.8.3 PRODUCT PORTFOLIO 247
13.8.4 RECENT DEVELOPMENTS 247
13.9 MEAD JOHNSON & COMPANY, LLC. 248
13.9.1 COMPANY SNAPSHOT 248
13.9.2 GEOGRAPHICAL PRESENCE 248
13.9.3 PRODUCT PORTFOLIO 248
13.9.4 RECENT DEVELOPMENTS 248
13.10 MEDLINE INDUSTRIES, INC 249
13.10.1 COMPANY SNAPSHOT 249
13.10.2 GEOGRAPHICAL PRESENCE 249
13.10.3 PRODUCT PORTFOLIO 250
13.10.4 RECENT DEVELOPMENTS 251
13.11 MEDTRITION, INC. 252
13.11.1 COMPANY SNAPSHOT 252
13.11.2 PRODUCT PORTFOLIO 252
13.11.3 NO RECENT DEVELOPMENTS 253
13.12 NUTRITIONAL MEDICINALS, LLC 254
13.12.1 COMPANY SNAPSHOT 254
13.12.2 GEOGRAPHICAL PRESENCE 254
13.12.3 PRODUCT PORTFOLIO 255
13.12.4 NO RECENT DEVELOPMENTS 255
13.13 REAL FOOD BLENDS 256
13.13.1 COMPANY SNAPSHOT 256
13.13.2 PRODUCT PORTFOLIO 256
13.13.3 RECENT DEVELOPMENTS 257
?
13.14 VICTUS 258
13.14.1 COMPANY SNAPSHOT 258
13.14.2 PRODUCT PORTFOLIO 258
13.14.3 RECENT DEVELOPMENTS 259
14 RELATED REPORTS 260